Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program.
about
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): Data from randomized controlled trials.Incretin-Based Therapy and Risk of Pancreatic Cancer in Patients with Type 2 Diabetes Mellitus: A Meta-analysis of Randomized Controlled Trials.Exenatide Add-on to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients with Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial.Chronic Pancreatitis in the 21st Century - Research Challenges and Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.Short-acting glucagon-like peptide-1 receptor agonists as add-on to insulin therapy in type 1 diabetes: A review.Sitagliptin Treatment After Total Pancreatectomy With Islet Autotransplantation: A Randomized, Placebo-Controlled Study.
P2860
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists Utilizing Data from the Exenatide Clinical Trial Development Program.
description
2016 nî lūn-bûn
@nan
2016 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Safety and Tolerability of Glu ...... cal Trial Development Program.
@ast
Safety and Tolerability of Glu ...... cal Trial Development Program.
@en
type
label
Safety and Tolerability of Glu ...... cal Trial Development Program.
@ast
Safety and Tolerability of Glu ...... cal Trial Development Program.
@en
prefLabel
Safety and Tolerability of Glu ...... cal Trial Development Program.
@ast
Safety and Tolerability of Glu ...... cal Trial Development Program.
@en
P2093
P2860
P1476
Safety and Tolerability of Glu ...... cal Trial Development Program.
@en
P2093
Laura L Want
Vanita R Aroda
P2860
P2888
P356
10.1007/S11892-016-0728-4
P577
2016-05-01T00:00:00Z
P6179
1051262493